ATP7B

Kat.-Nr. Produktname Informationen Produktzitate Produktvalidierungen
E1166 Tetrathiomolybdate (TM) Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
Advanced Science, 2025 Sep 4, 12(40):e05356
Phytomedicine, 2025, 143:156883
The FASEB Journal, 2025, e71250